By Alec Mattinson2020-02-28T08:34:00
Reckitt Benckiser has taken a £5bn impairment on the acquisition of baby formula maker Mead Johnson as its new chief executive seeks to draw a line under a period of underperformance.
Already have an account? Sign in here
Already have an account? Sign in here
You’ve used up your article allowance